US eClinical Solutions Market

The US eClinical solutions market is projected to reach USD 11.64 billion by 2030, up from USD 5.99 billion in 2025, at a CAGR of 14.2% over the forecast period. The market growth is driven by the rapid adoption of decentralized and hybrid trial models, an increased emphasis on real-time data capture, and the ongoing transition toward integrated clinical platforms that unify EDC, CTMS, RTSM, eCOA, and analytics capabilities. Stakeholders across biopharma, CROs, and research networks are prioritizing solutions that enhance operational efficiency, reduce protocol deviations, accelerate study timelines, and improve site sponsor patient connectivity.

Market activity in the US is shifting toward unified clinical technology platforms with deeper use of AI-driven analytics in trial operations. Vendors are consolidating capabilities to deliver connected ecosystems that reduce fragmentation and improve data traceability. Medidata’s Rave Clinical Cloud integrates EDC, eCOA, RTSM, and imaging on a single data backbone. Veeva’s Vault Clinical Suite is adopted by leading pharmaceutical companies to streamline CTMS, eTMF, and CDMS workflows within one architecture. The market is also seeing rapid adoption of AI and advanced analytics to support operational decisions. IQVIA applies machine learning within risk-based monitoring frameworks. Saama provides AI-enabled data quality and anomaly detection for complex oncology programs. Medidata uses predictive enrollment models powered by historical trial data to deliver real-time insights that improve forecasting accuracy and reduce delays. These shifts are reshaping buyer expectations and raising performance benchmarks across US clinical development.

To know about the assumptions considered for the study download the pdf brochure

The prominent players operating in the US eClinical solutions market include Medidata (A Dassault Systèmes Company) (France), Veeva Systems (US), IQVIA Inc. (US), Icon Plc (Ireland), Signant Health (US), Clario (US), Eclinical Solutions LLC (US), Oracle (US), Clinion (US), Maxisit (US), 4gGClinical (US), Fountayn (US), Saama (US), Crscube Inc. (South Korea), Advarra (US), Caidya (US), Openclinica, Llc (US), Evidentiq (Germany), Castor (US), and Medrio (US).

In August 2025, IQVIA Inc. (US) and Veeva Systems (US) announced a long-term partnership to integrate clinical data and analytics platforms, enabling faster database builds, quicker study closeouts, and improved trial efficiency.

In April 2025, eClinical Solutions (US) launched elluminate AI agents within its Clinical Data Cloud to automate data review and quality management, helping sponsors accelerate clinical trial execution and improve operational efficiency.

Medidata (France) remains one of the most influential players in the US eClinical landscape, leveraging a strategy centered on platform breadth and deep data intelligence. The company’s core competency lies in its unified Rave Clinical Cloud, which integrates EDC, eCOA, RTSM, and advanced analytics, enabling sponsors to manage trial complexity with high data fidelity. Medidata continues to strengthen its position through technological innovation, AI-enabled modules, and strategic collaborations across pharma, MedTech, and CRO ecosystems. The company has also expanded capabilities through acquisitions and vertical integration in areas such as imaging and real-world data, reinforcing its leadership in enterprise-scale deployments.

Veeva Systems (US) has emerged as a fast-scaling competitor with a strategy centered on cloud-native architecture and seamless data continuity across R&D functions. Its core competencies lie in Vault CDMS, Vault CTMS, and study-startup solutions that reduce operational friction and simplify regulatory alignment. Veeva’s development roadmap focuses on continuous innovation with modular expansion and stronger configurability. Its strategy includes long-term customer partnerships, ecosystem integrations, and horizontal expansion across quality, safety, and regulatory domains. This approach positions Veeva as a preferred option for sponsors moving away from legacy systems toward next-generation clinical platforms.

MARKET RANKING

The competitive landscape of the US eClinical solutions market is led by five major companies: Medidata (France), Veeva Systems (US), IQVIA Inc. (US), ICON Plc (Ireland), and Signant Health (US). These players shape market evolution through differentiated strategies and sustained technology investment. Medidata influences the market through its data-rich and full-stack clinical capabilities. Veeva drives cloud native transformation through its integrated Vault product family. IQVIA combines technology platforms with real-world data assets and CRO scale to deliver AI-enabled eClinical solutions. ICON integrates digital platforms into its clinical operations framework to advance technology-enabled trial execution. Signant Health adds depth with specialized eCOA, eConsent, and patient-centric technologies aligned with decentralized trials. Together, these companies set the innovation agenda and raise performance benchmarks for emerging and mid-market eClinical vendors.

Related Reports:

US eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech) Regulatory, Al, Growth, Market Size - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com